Search
Find Drugs
Advanced Search

 


Search Result For "targeted cancer therapy"
Brand No available data!
Generic No available data

Sutent

Tagrisso
Generic Name : osimertinib
Indication : 1st-line treatment of patients w/ locally advanced or metastatic NSCLC whose tumours have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations. Patients ...
Manufacturer : AstraZeneca
Distributor : Zuellig Pharma

Tarceva

Tasigna

Tepmetko
Generic Name : Tepotinib
Indication : Metastatic NSCLC harbouring mesenchymal-epithelial transition factor gene exon 14 skipping alterations.
Manufacturer : Merck

Torisel

Tykerb

Vectibix

Velcade

Votrient

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in .
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in .
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in